Chinese Pharmaceuticals & Biotech Spotless Management

Results

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

2 companies

Shanghai Allist Pharmaceuticals

Market Cap: CN¥41.5b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥92.26

-0.05%

6.9%

Xiamen Amoytop Biotech

Market Cap: CN¥23.5b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥57.52

-0.5%

-22.9%